Acadian Asset Management’s SOPHiA GENETICS SOPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$129K Buy
+22,600
New +$115K ﹤0.01% 1710
2026
Q1
Sell
-5,911
Closed -$27K 2245
2025
Q4
$27K Buy
+5,911
New +$26.8K ﹤0.01% 1874

Other funds holding SOPH

Acadian Asset Management's SOPH Position: Q2 2026 in Review

Acadian Asset Management opened a new position in SOPHiA GENETICS (SOPH) in Q2 2026: 22,600 shares worth $129K. The stake represents ﹤0.01% of the portfolio and ranks #1710 among its holdings. This is a return to the name: Acadian Asset Management previously reported a position in SOPH as recently as Q4 2025.

Acadian Asset Management first reported a position in SOPH in Q4 2025 and has held it in 2 quarters since. 72 funds tracked by Wall St. Rank hold SOPH as of Q2 2026.

  • Acadian Asset Management held 22,600 shares of SOPHiA GENETICS worth $129K as of Q2 2026.
  • SOPHiA GENETICS was a new Acadian Asset Management position in Q2 2026.
  • SOPHiA GENETICS made up ﹤0.01% of Acadian Asset Management's portfolio in Q2 2026, its #1710 holding.
  • Acadian Asset Management first reported a position in SOPHiA GENETICS in Q4 2025 and has held it in 2 quarters since.
  • 72 funds tracked by Wall St. Rank held SOPHiA GENETICS as of Q2 2026.

Based on Acadian Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.